Main
>
ONCOLOGY (**)
>
Lung>NSCLC>MET>PD-L1+>> ***
>
Treatment
>
UK. A. DurvaluMAb ***
>
(*) USA Approval Date: 2018. 02.19.
(*) USA Approval Date: 2018. 02.19.'s products
This section has no products